Literature DB >> 33732635

Clinicopathological and Molecular Analysis of 45 Cases of Pure Mucinous Breast Cancer.

Hyun Ee Yim1, Jang-Hee Kim1, Mi Sun Ahn2, Yongsik Jung3, Jin Roh1, So Hyun Park1, Tae-Gyu Kim1, Jin-Hyuk Choi2, Seok Yun Kang2.   

Abstract

Pure mucinous breast carcinoma (PMBC) is characterized by clusters of tumor cells floating in abundant extracellular mucin and can be classified into paucicellular (Type A) and hypercellular (Type B) subtypes. However, the clinicopathological and genomic differences between these two subtypes have not been well characterized. We retrospectively investigated the clinicopathologic features of 45 cases of surgically removed PMBC (31 Type A and 14 Type B). We also performed whole-exome sequencing (WES) in eight cases of PMBC. We found that Type B PMBC occurs at an older age and shows more aggressive clinical behavior than Type A. WES analysis revealed that HYDIN was the most frequently mutated gene in both types of PMBC. Although Type B PMBC showed a tendency toward more frequent genetic alterations, there were no statistically significant differences between the two subtypes in single nucleotide variants or insertions or deletions of bases associated with moderate or high effects. Our results provide additional evidence that PMBCs are clinicopathologically and genetically heterogeneous and lack pathognomonic genetic alterations. Further, Type B PMBC is more frequently associated with lymph node metastasis than Type A.
Copyright © 2021 Yim, Kim, Ahn, Jung, Roh, Park, Kim, Choi and Kang.

Entities:  

Keywords:  Immunohistochemistry; breast cancer; histological type; mucinous carcinoma; whole-exome sequencing

Year:  2021        PMID: 33732635      PMCID: PMC7956951          DOI: 10.3389/fonc.2020.558760

Source DB:  PubMed          Journal:  Front Oncol        ISSN: 2234-943X            Impact factor:   6.244


  45 in total

1.  The Catalogue of Somatic Mutations in Cancer (COSMIC).

Authors:  S A Forbes; G Bhamra; S Bamford; E Dawson; C Kok; J Clements; A Menzies; J W Teague; P A Futreal; M R Stratton
Journal:  Curr Protoc Hum Genet       Date:  2008-04

2.  Mucinous breast carcinoma: a large contemporary series.

Authors:  Christina R Barkley; Jennifer A Ligibel; Julia S Wong; Stuart Lipsitz; Barbara L Smith; Mehra Golshan
Journal:  Am J Surg       Date:  2008-10       Impact factor: 2.565

3.  Recessive HYDIN mutations cause primary ciliary dyskinesia without randomization of left-right body asymmetry.

Authors:  Heike Olbrich; Miriam Schmidts; Claudius Werner; Alexandros Onoufriadis; Niki T Loges; Johanna Raidt; Nora Fanni Banki; Amelia Shoemark; Tom Burgoyne; Saeed Al Turki; Matthew E Hurles; Gabriele Köhler; Josef Schroeder; Gudrun Nürnberg; Peter Nürnberg; Eddie M K Chung; Richard Reinhardt; June K Marthin; Kim G Nielsen; Hannah M Mitchison; Heymut Omran
Journal:  Am J Hum Genet       Date:  2012-09-27       Impact factor: 11.025

4.  Tumor characteristics and clinical outcome of tubular and mucinous breast carcinomas.

Authors:  S G Diab; G M Clark; C K Osborne; A Libby; D C Allred; R M Elledge
Journal:  J Clin Oncol       Date:  1999-05       Impact factor: 44.544

5.  A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.

Authors:  Salomone Di Saverio; Juan Gutierrez; Eli Avisar
Journal:  Breast Cancer Res Treat       Date:  2007-11-18       Impact factor: 4.872

6.  Mucinous and neuroendocrine breast carcinomas are transcriptionally distinct from invasive ductal carcinomas of no special type.

Authors:  Britta Weigelt; Felipe C Geyer; Hugo M Horlings; Bas Kreike; Hans Halfwerk; Jorge S Reis-Filho
Journal:  Mod Pathol       Date:  2009-07-24       Impact factor: 7.842

7.  CNVkit: Genome-Wide Copy Number Detection and Visualization from Targeted DNA Sequencing.

Authors:  Eric Talevich; A Hunter Shain; Thomas Botton; Boris C Bastian
Journal:  PLoS Comput Biol       Date:  2016-04-21       Impact factor: 4.475

8.  Clinicopathological Characteristics of Mucinous Breast Cancer: A Retrospective Analysis of a 10-Year Study.

Authors:  Lei Lei; Xingfei Yu; Bo Chen; Zhanhong Chen; Xiaojia Wang
Journal:  PLoS One       Date:  2016-05-27       Impact factor: 3.240

9.  Fast and accurate short read alignment with Burrows-Wheeler transform.

Authors:  Heng Li; Richard Durbin
Journal:  Bioinformatics       Date:  2009-05-18       Impact factor: 6.937

10.  Signatures of mutational processes in human cancer.

Authors:  Ludmil B Alexandrov; Serena Nik-Zainal; David C Wedge; Samuel A J R Aparicio; Sam Behjati; Andrew V Biankin; Graham R Bignell; Niccolò Bolli; Ake Borg; Anne-Lise Børresen-Dale; Sandrine Boyault; Birgit Burkhardt; Adam P Butler; Carlos Caldas; Helen R Davies; Christine Desmedt; Roland Eils; Jórunn Erla Eyfjörd; John A Foekens; Mel Greaves; Fumie Hosoda; Barbara Hutter; Tomislav Ilicic; Sandrine Imbeaud; Marcin Imielinski; Marcin Imielinsk; Natalie Jäger; David T W Jones; David Jones; Stian Knappskog; Marcel Kool; Sunil R Lakhani; Carlos López-Otín; Sancha Martin; Nikhil C Munshi; Hiromi Nakamura; Paul A Northcott; Marina Pajic; Elli Papaemmanuil; Angelo Paradiso; John V Pearson; Xose S Puente; Keiran Raine; Manasa Ramakrishna; Andrea L Richardson; Julia Richter; Philip Rosenstiel; Matthias Schlesner; Ton N Schumacher; Paul N Span; Jon W Teague; Yasushi Totoki; Andrew N J Tutt; Rafael Valdés-Mas; Marit M van Buuren; Laura van 't Veer; Anne Vincent-Salomon; Nicola Waddell; Lucy R Yates; Jessica Zucman-Rossi; P Andrew Futreal; Ultan McDermott; Peter Lichter; Matthew Meyerson; Sean M Grimmond; Reiner Siebert; Elías Campo; Tatsuhiro Shibata; Stefan M Pfister; Peter J Campbell; Michael R Stratton
Journal:  Nature       Date:  2013-08-14       Impact factor: 49.962

View more
  4 in total

1.  ETS1 Ameliorates Hyperoxia-Induced Alveolar Epithelial Cell Injury by Regulating the TGM2-Mediated Wnt/β-Catenin Pathway.

Authors:  Min Yang; Xi-Rong Gao; Yan-Ni Meng; Fang Shen; Yan-Ping Chen
Journal:  Lung       Date:  2021-11-24       Impact factor: 2.584

Review 2.  Focused ultrasound: growth potential and future directions in neurosurgery.

Authors:  Michael Zhang; Adrian Rodrigues; Quan Zhou; Gordon Li
Journal:  J Neurooncol       Date:  2021-08-19       Impact factor: 4.130

3.  Pure Mucinous Breast Carcinoma With a Favorable Tumor Biology and Clinical Outcomes.

Authors:  Selman Emiroglu; Mustafa Tukenmez; Seyma Karakus; Hasan Karanlik; Semen Onder; Vahit Ozmen; Neslihan Cabioglu; Enver Ozkurt; Ravza Yilmaz; Mahmut Muslumanoglu
Journal:  Eur J Breast Health       Date:  2022-10-01

Review 4.  Quantitative proteomics characterization of cancer biomarkers and treatment.

Authors:  Xiao-Li Yang; Yi Shi; Dan-Dan Zhang; Rui Xin; Jing Deng; Ting-Miao Wu; Hui-Min Wang; Pei-Yao Wang; Ji-Bin Liu; Wen Li; Yu-Shui Ma; Da Fu
Journal:  Mol Ther Oncolytics       Date:  2021-04-20       Impact factor: 7.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.